Real-World Evidence for Favourable Quality-of-Life Outcomes in Hungarian Patients with Relapsing-Remitting Multiple Sclerosis Treated for Two Years with Oral Teriflunomide: Results of the Teri-REAL Study

• Главные авторы: Krisztina Bencsik (Автор), Enikő Dobos (Автор), Zita Jobbágy (Автор), Adrienne Jóri Birkás (Автор), Krisztina Kovács (Автор), Mária Sátori (Автор), Gyula Lencsés (Автор), Gabor Bartok (Автор), Erika Losonczi (Автор), László Vécsei (Автор), on behalf of the Teri-REAL Investigators (Автор)
• Формат: ‌
• Опубликовано: MDPI AG, 2022-05-01T00:00:00Z.
• Предметы: article
• Online-ссылка: Connect to this object online.

Relapsing-remitting multiple sclerosis (RRMS) is a degenerative, inflammatory disease of the central nervous system in which symptoms and disability progression vary significantly among patients. Teri-REAL was a prospective, real-world observational study that examined quality-of-life (QoL) and trea...